Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...
A new study finds that an easily measurable brain wave shift of phase may be a universal marker of unconsciousness under general anesthesia. At the level of molecules and cells, ketamine and ...
– Alignment achieved with U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for EMPEROR – – One-year study of ...
Giving a shot in the arm to the dream of revolutionising urban mobility and fuelling sustainable economic growth in the capital, the State government on Friday approved the first phase alignment of ...
- Overall survival update for Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients planned in coming weeks - NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Immuneering ...